Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXR0WO
|
||||
| Drug Name |
(S)-1-(1H-indol-4-yloxy)-3-((2S,4R)-4-(benzo[b]thiophen-2-yl)-2-methylpiperidin-1-yl)propan-2-ol
|
||||
| Synonyms |
CHEMBL311701
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C25H28N2O2S
|
||||
| Canonical SMILES |
C[C@H]1C[C@@H](CCN1C[C@H](O)COc2cccc3[nH]ccc23)c4cc5ccccc5s4
|
||||
| InChI |
InChI=1S/C25H28N2O2S/c1-17-13-19(25-14-18-5-2-3-8-24(18)30-25)10-12-27(17)15-20(28)16-29-23-7-4-6-22-21(23)9-11-26-22/h2-9,11,14,17,19-20,26,28H,10,12-13,15-16H2,1H3/t17-,19+,20-/m0/s1
|
||||
| InChIKey |
RHSFODFYAUATPZ-SXLOBPIMSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.